Drug Topics September 2, 2024
Catch up on important immunization news from the month of August.
COVID-19: FDA Approves, Grants EUA to Moderna, Pfizer 2024-2025 Vaccine Formulations
The FDA approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines manufactured by Moderna and Pfizer to include a monovalent component corresponding to the KP.2 variant of the Omicron strain of SARS-CoV-2. These vaccines, the FDA noted in a news release, now “more closely target currently circulating variants and provide better protection against serious consequences of COVID-19.”
Q&A: How Health Care Providers Can Help Increase COVID-19 Vaccine Uptake
Drug Topics recently talked with Chijioke Bennett, MD, MPH, MBA, executive director of clinical development at Novavax, about how health care providers can increase awareness around the...
Today's Sponsors
Today's Sponsor